SCHEMBL4451400

SCHEMBL4451400

C[CH]C(C)(C)CN(C)S(C)(=O)=O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1697335 0.75 MEN1 (0.41) MEN1KMT2A
SCHEMBL24571659 0.72 MEN1 (0.42) MEN1KMT2A
SCHEMBL24856017 0.67 MEN1 (0.31) MEN1KMT2A
SCHEMBL4415249 0.65
SCHEMBL4406577 0.65 MEN1 (0.37) MEN1KMT2A
SCHEMBL15384953 0.64 MEN1 (0.32) MEN1KMT2A
SCHEMBL13726975 0.62 MEN1 (0.38) MEN1KMT2A
SCHEMBL1937404 0.61
SCHEMBL15471252 0.60 MEN1 (0.37) MEN1KMT2A
SCHEMBL6268717 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029153-A2 HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR Phenomix Corporation (US) 2009-03-04 EP claimed
WO-2007089618-A2 HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR PHENOMIX CORPORATION (US) 2007-08-09 WO claimed